Post-market Reviews of Chronic Obstructive Pulmonary Disease (COPD) medicines and Ezetimibe – Public Consultation
Page last updated: 4 March 2016
The public submission process is now open for the Post-market Reviews of:
- Chronic Obstructive Pulmonary Disease medicines; and
Interested organisations and individuals are invited to provide a submission addressing the Reviews’ Terms of Reference. To make a submission please go to the relevant Public Consultation page:
The public submission process will be open for 7 weeks and will close at 5pm Friday, 22 April 2016.